This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ultragenyx Pharmaceutical Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Lorelei Ioana Stoica and Gene Therapy Research
Introduction
Lorelei Ioana Stoica is an inventor associated with Acton, Massachusetts, and Ultragenyx Pharmaceutical Inc. Her patent work includes an invention focused on gene therapy for CDKL5 deficiency disorder.
Latest Patents
Stoica is listed as an inventor on 1 patent: “Gene Therapy for Treating CDKL5 Deficiency Disorder.” The patent concerns a gene therapy approach for a rare neurological condition.
Career Highlights
Her listed patent connects her work with Ultragenyx Pharmaceutical Inc., a company involved in developing treatments for rare and serious diseases.
Collaborations
Stoica’s named co-inventors include Sean Christopher Daugherty and Margaret Caroline Wright. Their shared patent reflects collaborative work on gene therapy for CDKL5 deficiency disorder.
Conclusion
Lorelei Ioana Stoica’s patent record highlights her contribution to collaborative gene therapy research addressing CDKL5 deficiency disorder.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile